Cargando…

How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study

OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Asuka, Fujimaki, Yuko, Fujimori, Shin, Isogawa, Akihiro, Onishi, Yukiko, Suzuki, Ryo, Ueki, Kohjiro, Yamauchi, Toshimasa, Kadowaki, Takashi, Hashimoto, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239528/
https://www.ncbi.nlm.nih.gov/pubmed/32423931
http://dx.doi.org/10.1136/bmjopen-2019-034757
_version_ 1783536708729438208
author Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
author_facet Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
author_sort Kato, Asuka
collection PubMed
description OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient activation for self-care, we tested a two-path hypothetical model both directly and as mediated by self-esteem and self-efficacy. DESIGN: A cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Japan. PARTICIPANTS: T2DM outpatients receiving treatment (n=209) completed a self-administered questionnaire comprising the Self-Stigma Scale, Patient Activation Measure, Rosenberg Self-Esteem Scale, General Self-Efficacy Scale, Patient Health Questionnaire, haemoglobin A1c test, age, sex and body mass index. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma levels were measured by using the Self-Stigma Scale. Patient activation levels were measured by the Patient Activation Measure. RESULTS: Path analysis showed a strong relationship between self-stigma and patient activation (χ(2)=27.55, p=0.120; goodness-of-fit index=0.97; adjusted goodness-of-fit index=0.94; comparative fit index=0.98; root mean square error of approximation=0.04). Self-stigma had a direct effect on patient activation (β=−0.20; p=0.002). Indirectly, self-stigma affected patient activation along two paths (β=0.31; p<0.001) by reducing self-esteem (β=−0.22; p<0.001) and self-efficacy (β=−0.36; p<0.001). CONCLUSIONS: Due to the cross-sectional design of the study, longitudinal changes between all the variables cannot be established. However, the findings indicate that self-stigma affected patient activation for self-care, both directly and as mediated by self-esteem and self-efficacy. Interventions that increase self-esteem and self-efficacy may decrease self-stigma in patients with T2DM, thus increasing patient activation for self-care.
format Online
Article
Text
id pubmed-7239528
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72395282020-05-28 How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki BMJ Open Diabetes and Endocrinology OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient activation for self-care, we tested a two-path hypothetical model both directly and as mediated by self-esteem and self-efficacy. DESIGN: A cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Japan. PARTICIPANTS: T2DM outpatients receiving treatment (n=209) completed a self-administered questionnaire comprising the Self-Stigma Scale, Patient Activation Measure, Rosenberg Self-Esteem Scale, General Self-Efficacy Scale, Patient Health Questionnaire, haemoglobin A1c test, age, sex and body mass index. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma levels were measured by using the Self-Stigma Scale. Patient activation levels were measured by the Patient Activation Measure. RESULTS: Path analysis showed a strong relationship between self-stigma and patient activation (χ(2)=27.55, p=0.120; goodness-of-fit index=0.97; adjusted goodness-of-fit index=0.94; comparative fit index=0.98; root mean square error of approximation=0.04). Self-stigma had a direct effect on patient activation (β=−0.20; p=0.002). Indirectly, self-stigma affected patient activation along two paths (β=0.31; p<0.001) by reducing self-esteem (β=−0.22; p<0.001) and self-efficacy (β=−0.36; p<0.001). CONCLUSIONS: Due to the cross-sectional design of the study, longitudinal changes between all the variables cannot be established. However, the findings indicate that self-stigma affected patient activation for self-care, both directly and as mediated by self-esteem and self-efficacy. Interventions that increase self-esteem and self-efficacy may decrease self-stigma in patients with T2DM, thus increasing patient activation for self-care. BMJ Publishing Group 2020-05-17 /pmc/articles/PMC7239528/ /pubmed/32423931 http://dx.doi.org/10.1136/bmjopen-2019-034757 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title_full How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title_fullStr How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title_full_unstemmed How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title_short How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
title_sort how self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239528/
https://www.ncbi.nlm.nih.gov/pubmed/32423931
http://dx.doi.org/10.1136/bmjopen-2019-034757
work_keys_str_mv AT katoasuka howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT fujimakiyuko howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT fujimorishin howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT isogawaakihiro howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT onishiyukiko howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT suzukiryo howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT uekikohjiro howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT yamauchitoshimasa howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT kadowakitakashi howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy
AT hashimotohideki howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy